awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38201162-DB1F14C3-6350-4B0C-A35A-66858141DAB6
Q38201162-DB1F14C3-6350-4B0C-A35A-66858141DAB6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38201162-DB1F14C3-6350-4B0C-A35A-66858141DAB6
Lowering plasma glucose concentration by inhibiting renal sodium-glucose cotransport.
P2860
Q38201162-DB1F14C3-6350-4B0C-A35A-66858141DAB6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38201162-DB1F14C3-6350-4B0C-A35A-66858141DAB6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
dd55c6c2c4675b89820544388f307a329a7b8eec
P2860
Remogliflozin etabonate, a selective inhibitor of the sodium-dependent transporter 2 reduces serum glucose in type 2 diabetes mellitus patients.